Procter & Gamble Hygiene & Health Care news

   Watch this stock
Showing stories 1 - 10 of about 74   

Articles published

500459 6,400.00 -1.35 (-0.02%)
price chart
Procter & Gamble Hygiene and Health Care Q3 profit up 7.59% at Rs 87 crore
"Both the feminine care and health care businesses continued to deliver strong sales growth in a competitive market environment behind superior value propositions and strength of products portfolio.
Right Time + Right Stock + Right Investment = HIGH PROFIT
Procter and Gamble Hygiene and Health Care. BSE: 500459 | NSE: PGHH | ISIN: INE179A01014 | SECTOR: PERSONAL CARE · SET SMS ALERT.
Procter & Gamble Hygiene and Health Care net profit up 12%
Mumbai: Procter & Gamble Hygiene and Health Care Ltd reported a 12% increase in net profit to Rs.97.30 crore for the third quarter ended 31 March, from Rs.86.89 crore a year-ago.
Procter & Gamble Hygiene and Health Care Q2 net profit up 13%
Procter & Gamble Hygiene and Health Care Ltd has posted a net profit of Rs. 697.80 mn for the quarter ended September 30, 2015 as compared to Rs.
Procter & Gamble Q1 Net Up 13% at Rs. 70 Crore  NDTV
Procter & Gamble to rise in sanitary segment, while facing competition in ...
Procter & Gamble Hygiene and Health Care (P&GHH), which sells female hygiene products under the Whisper brand, and healthcare products under the Vicks brand, could be a strong multi-year compounding story. The shares of the India-listed subsidiary of ...
Procter & Gamble net profit rises nearly 62% in December quarter
Procter and Gamble Hygiene and Health Care (P&G), a leading FMCG player, on Saturday, reported a 61.81% rise in the net profit to Rs 146.7 crore for the second quarter (Q2) ended December 31, 2015.
P&G Net Up 62% to Rs. 147 Crore in Q2  NDTV
P&G India's focus on margins weighs on sales
Details of its most recent profit and revenue numbers aren't available for India, where P&G's listed unit, Procter & Gamble Hygiene & Health Care, is scheduled to release quarterly results on May 5. P&G's three entities in India, selling products ...
P&G moving away from unprofitable businesses in India: Global CFO  Business Standard
Pfizer, Abbott, Procter & Gamble Shares Hit By Drug Ban
The product is a fixed dose combination of paracetamol, phenylephrine and caffeine, which was banned by health ministry in a notice issued over the weekend, Procter & Gamble Hygiene and Health Care informed the stock exchange. The healthcare ...
Delhi HC stays govt order banning drugs made by Abbott, Macleods  Livemint
P&G slips 2%; stops selling Vicks Action 500 Extra in India after ban
Procter & Gamble's India slipped 2% to Rs.6,000 after the company said it had stopped manufacture and sale of its cough-and-cold medicine Vicks Action 500 Extra with immediate effect, after regulators banned it citing potential health risk. Though ...
Procter & Gamble to challenge ban on Vicks Action 500 Extra  Economic Times
P&G stabilises its operations in India
Procter & Gamble Hygiene and Healthcare, the other listed company, reported double-digit revenue growth for a second quarter in a row.